These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Exendin-4 protects beta-cells from interleukin-1 beta-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway. Ferdaoussi M; Abdelli S; Yang JY; Cornu M; Niederhauser G; Favre D; Widmann C; Regazzi R; Thorens B; Waeber G; Abderrahmani A Diabetes; 2008 May; 57(5):1205-15. PubMed ID: 18252896 [TBL] [Abstract][Full Text] [Related]
5. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase. Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440 [TBL] [Abstract][Full Text] [Related]
6. Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies. Tsunekawa S; Yamamoto N; Tsukamoto K; Itoh Y; Kaneko Y; Kimura T; Ariyoshi Y; Miura Y; Oiso Y; Niki I J Endocrinol; 2007 Apr; 193(1):65-74. PubMed ID: 17400804 [TBL] [Abstract][Full Text] [Related]
7. Effects of glucose and insulin on glucokinase activity in rat hypothalamus. Sanz C; Roncero I; Vázquez P; Navas MA; Blázquez E J Endocrinol; 2007 May; 193(2):259-67. PubMed ID: 17470517 [TBL] [Abstract][Full Text] [Related]
8. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats. Park S; Hong SM; Sung SR Life Sci; 2008 Feb; 82(9-10):503-11. PubMed ID: 18237751 [TBL] [Abstract][Full Text] [Related]
9. Exendin-4 inhibits interleukin-1beta-induced iNOS expression at the protein level, but not at the transcriptional and posttranscriptional levels, in RINm5F beta-cells. Kang JH; Chang SY; Jang HJ; Kim DB; Ryu GR; Ko SH; Jeong IK; Jo YH; Kim MJ J Endocrinol; 2009 Jul; 202(1):65-75. PubMed ID: 19398497 [TBL] [Abstract][Full Text] [Related]
10. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity. Ghanaat-Pour H; Sjöholm A Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603 [TBL] [Abstract][Full Text] [Related]
11. Exendin-4 induction of Egr-1 expression in INS-1 beta-cells: interaction of SRF, not YY1, with SRE site of rat Egr-1 promoter. Kim MJ; Kang JH; Chang SY; Jang HJ; Ryu GR; Ko SH; Jeong IK; Kim MS; Jo YH J Cell Biochem; 2008 Aug; 104(6):2261-71. PubMed ID: 18446785 [TBL] [Abstract][Full Text] [Related]
12. Calcium/calmodulin-dependent serine protein kinase is involved in exendin-4-induced insulin secretion in INS-1 cells. Zhu ZQ; Wang D; Xiang D; Yuan YX; Wang Y Metabolism; 2014 Jan; 63(1):120-6. PubMed ID: 24140090 [TBL] [Abstract][Full Text] [Related]
13. Octanoic acid potentiates glucose-stimulated insulin secretion and expression of glucokinase through the olfactory receptor in pancreatic β-cells. Leem J; Shim HM; Cho H; Park JH Biochem Biophys Res Commun; 2018 Sep; 503(1):278-284. PubMed ID: 29885841 [TBL] [Abstract][Full Text] [Related]
14. Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride. Müller G; Korndörfer A; Kornak U; Malaisse WJ Arch Biochem Biophys; 1994 Jan; 308(1):8-23. PubMed ID: 8311478 [TBL] [Abstract][Full Text] [Related]
15. Circadian and age-dependent expression patterns of GLUT2 and glucokinase in the pancreatic beta-cell of diabetic and nondiabetic rats. Frese T; Bazwinsky I; Mühlbauer E; Peschke E Horm Metab Res; 2007 Aug; 39(8):567-74. PubMed ID: 17712721 [TBL] [Abstract][Full Text] [Related]
17. Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway. Arrázola MS; Varela-Nallar L; Colombres M; Toledo EM; Cruzat F; Pavez L; Assar R; Aravena A; González M; Montecino M; Maass A; Martínez S; Inestrosa NC J Cell Physiol; 2009 Dec; 221(3):658-67. PubMed ID: 19711354 [TBL] [Abstract][Full Text] [Related]
18. Calcium/calmodulin kinase IV pathway is involved in the transcriptional regulation of the corticotropin-releasing hormone gene promoter in neuronal cells. Yamamori E; Asai M; Yoshida M; Takano K; Itoi K; Oiso Y; Iwasaki Y J Mol Endocrinol; 2004 Dec; 33(3):639-49. PubMed ID: 15591024 [TBL] [Abstract][Full Text] [Related]
19. Cell biology assessment of glucokinase mutations V62M and G72R in pancreatic beta-cells: evidence for cellular instability of catalytic activity. Arden C; Trainer A; de la Iglesia N; Scougall KT; Gloyn AL; Lange AJ; Shaw JA; Matschinsky FM; Agius L Diabetes; 2007 Jul; 56(7):1773-82. PubMed ID: 17389332 [TBL] [Abstract][Full Text] [Related]
20. Regulation of liver glucokinase activity in rats with fructose-induced insulin resistance and impaired glucose and lipid metabolism. Francini F; Castro MC; Gagliardino JJ; Massa ML Can J Physiol Pharmacol; 2009 Sep; 87(9):702-10. PubMed ID: 19794521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]